Skip to content

Peak Bio, Inc.

CIK 0001834645

← back to feed
Revenue (TTM)
$278.83K
−39.5% YoY Q3 Nov 2024
Net Income (TTM)
−$2.39M
+2.0% YoY Q3 Nov 2024
EPS Diluted (TTM)
−$0.13
+17.6% YoY Q3 Nov 2024
Gross Margin
—
Q3 Nov 2024
Operating Margin
-2,553.1%
Q3 Nov 2024
Net Margin
-856.4%
Q3 Nov 2024
Free Cash Flow (TTM)
−$4.42M
Q3 Nov 2024
Cash
$862.14K
Q3 Nov 2024
Total Debt
$5.6M
Q3 Nov 2024
Shares Outstanding
23.12M sh
Q3 Nov 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings